Skip to content
10-Q

Quarterly Report

TriSalus Life Sciences, Inc. TLSI TLSIW

0001826667-25-000117

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 6, 2025 49.87M sh
Shares Diluted Q2 2025 · Jun 30, 2025 32.9M sh
Shares Diluted Q2 2025 · Jun 30, 2025 30.71M sh
Shares Diluted Q2 2025 · Jun 30, 2024 23.9M sh
Shares Diluted Q2 2025 · Jun 30, 2024 23.61M sh
Capex Q2 2025 · Jun 30, 2025 $661K
Capex Q2 2025 · Jun 30, 2024 $126K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$11.82M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$24.29M
Long Term Debt Q2 2025 · Jun 30, 2025 $32.27M
Long Term Debt Q2 2025 · Dec 31, 2024 $22.08M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $26.49M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $8.53M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$19.42M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$34.37M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$25.89M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 −$25.26M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 −$36.04M
Stockholders Equity restated Q2 2025 · Dec 31, 2023 −$27.07M
Current Liabilities Q2 2025 · Jun 30, 2025 $9.32M
Current Liabilities Q2 2025 · Dec 31, 2024 $10.23M
Total Liabilities Q2 2025 · Jun 30, 2025 $60.74M
Total Liabilities Q2 2025 · Dec 31, 2024 $49.87M
Current Assets Q2 2025 · Jun 30, 2025 $38.08M
Current Assets Q2 2025 · Dec 31, 2024 $20.67M
Total Assets Q2 2025 · Jun 30, 2025 $41.32M
Total Assets Q2 2025 · Dec 31, 2024 $23.97M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.27
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.65
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.21
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.81
Eps Basic Q2 2025 · Jun 30, 2025 −$0.27
Eps Basic Q2 2025 · Jun 30, 2025 −$0.65
Eps Basic Q2 2025 · Jun 30, 2024 −$0.21
Eps Basic Q2 2025 · Jun 30, 2024 −$0.81
Sga Expense Q2 2025 · Jun 30, 2025 $5.66M
Sga Expense Q2 2025 · Jun 30, 2025 $10.63M
Sga Expense Q2 2025 · Jun 30, 2024 $3.96M
Sga Expense Q2 2025 · Jun 30, 2024 $8.58M
Rd Expense Q2 2025 · Jun 30, 2025 $3.92M
Rd Expense Q2 2025 · Jun 30, 2025 $7.22M
Rd Expense Q2 2025 · Jun 30, 2024 $4.67M
Rd Expense restated Q2 2025 · Jun 30, 2024 $10.51M
Net Income Q2 2025 · Jun 30, 2025 −$8.29M
Net Income Q2 2025 · Jun 30, 2025 −$18.66M
Net Income Q2 2025 · Mar 31, 2025 −$10.38M
Net Income Q2 2025 · Jun 30, 2024 −$4.33M
Net Income restated Q2 2025 · Jun 30, 2024 −$17.54M
Net Income restated Q2 2025 · Mar 31, 2024 −$13.21M
Operating Income Q2 2025 · Jun 30, 2025 −$7.33M
Operating Income Q2 2025 · Jun 30, 2025 −$14.66M
Operating Income Q2 2025 · Jun 30, 2024 −$8.17M
Operating Income restated Q2 2025 · Jun 30, 2024 −$19.85M
Gross Profit Q2 2025 · Jun 30, 2025 $9.41M
Gross Profit Q2 2025 · Jun 30, 2025 $17.08M
Gross Profit Q2 2025 · Jun 30, 2024 $6.45M
Gross Profit Q2 2025 · Jun 30, 2024 $11.94M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $1.8M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $3.3M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $912K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1.88M
Revenue Q2 2025 · Jun 30, 2025 $11.21M
Revenue Q2 2025 · Jun 30, 2025 $20.38M
Revenue Q2 2025 · Jun 30, 2024 $7.36M
Revenue Q2 2025 · Jun 30, 2024 $13.82M